NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News  » Business » Aurobindo gets FDA nod for drug

Aurobindo gets FDA nod for drug

September 27, 2005 12:48 IST

Aurobindo Pharma Ltd on Tuesday said it has received tentative approval from the US FDA for its Sertraline Hydrochloride ANDA for tablets of 25 mg (base), 50 mg (base) and 100 mg (base).

The company will be able to market this product in the US after the expiry of the Sertraline Hydrochloride product patent and also upon final approval from US FDA, it informed the Bombay Stock Exchange.

US FDA has termed its generic drug product to be bio-equivalent and have the same therapeutic effect to the innovator product, namely Zoloft of Pfizer Inc, it said.

The company is already selling three formulations in the US and the strategy is kept right to penetrate the US market, it added.

© Copyright 2018 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.